Susquehanna International Group
IPSC icon

Susquehanna International Group’s Century Therapeutics IPSC Stock Holding History

Susquehanna International Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,300
Closed -$155K – 13019
2022
Q4 		$155K Buy
30,300
+1,000
+3% +$9.44K ﹤0.01% 10455
2022
Q3 		$290K Buy
+29,300
New +$309K ﹤0.01% 9877

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Susquehanna International Group's IPSC Position: Q2 2026 in Review

Susquehanna International Group reduced its Century Therapeutics (IPSC) stake by 49% in Q2 2026, selling an estimated $253K and leaving 115,792 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #11174.

Susquehanna International Group first reported a position in IPSC in Q2 2021 and has held it in 11 quarters since. The position peaked at $675K in Q2 2021. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Susquehanna International Group held 115,792 shares of Century Therapeutics worth $284K as of Q2 2026.
  • Susquehanna International Group sold 110,895 Century Therapeutics shares in Q2 2026, an estimated $253K.
  • Century Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #11174 holding.
  • Susquehanna International Group first reported a position in Century Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • Susquehanna International Group's Century Therapeutics position peaked at $675K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.